MEDICINES

This tender concerns the procurement of medicines, identified under the reference AQ 2023_491, with an initial duration of two months. The specific details regarding the types and quantities of medicines required, the exact location for delivery, and the contracting authority are not provided in the brief description. However, the title clearly indicates that the subject matter is the acquisition of pharmaceutical products. This type of procurement is crucial for healthcare systems, ensuring the availability of essential drugs for public health services, hospitals, or clinics. The tender likely involves competitive bidding processes where qualified suppliers will be invited to submit proposals. Key aspects of such tenders typically include adherence to quality standards, regulatory compliance (e.g., Good Manufacturing Practices, Good Distribution Practices), competitive pricing, and reliable supply chain management. Further details would be expected in the full tender documentation, which would outline the technical specifications, evaluation criteria, contract terms, and submission deadlines. The short duration mentioned (2 months) might suggest a specific, immediate need or a preliminary phase of a larger procurement strategy. Interested parties should consult the complete tender notice for comprehensive information.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 192.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.